The nurse-based age independent intervention to limit evolution of disease after acute coronary syndrome (NAILED ACS) risk factor trial: Protocol for a randomized controlled trial

JMIR Research Protocols

Volumn 3, Issue 3, 2014, Pages

  Mooe, Thomas ^a   Björklund, Fredrik ^a   Graipe, Anna ^b   Huber, Daniel ^a   Jakobsson, Stina ^a   Kajermo, Ulf ^c   Strömvall, Anna ^b   Ulvenstam, Anders ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b ÖSTERSUND HOSPITAL   (Sweden)

^c SKARABORG HOSPITAL   (Sweden)

Author keywords

Acute coronary syndrome; Cardiovascular disease; Myocardial infarction; Randomized controlled trial; Secondary prevention

Indexed keywords

EID: 85086938318     PISSN: None     EISSN: 19290748     Source Type: Journal    
DOI: 10.2196/resprot.3466     Document Type: Article

References (17)

1. Smith SC, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: Endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006 May 16; 113(19):2363-2372 [FREE Full text] [doi: 10.1161/CIRCULATIONAHA.106.174516] [Medline: 16702489]
2. Buckley BS, Byrne MC, Smith SM. Service organisation for the secondary prevention of ischaemic heart disease in primary care. Cochrane Database Syst Rev 2010(3):CD006772. [doi: 10.1002/14651858.CD006772.pub2] [Medline: 20238349]
3. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U. Cardiovascular prevention guidelines in daily practice: A comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 2009 Mar 14; 373(9667):929-940. [doi: 10.1016/S0140-6736(09)60330-5] [Medline: 19286092]
4. Vale MJ, Jelinek MV, Best JD, Santamaria JD. Coaching patients with coronary heart disease to achieve the target cholesterol: A method to bridge the gap between evidence-based medicine and the "real world"-randomized controlled trial. J Clin Epidemiol 2002 Mar; 55(3):245-252. [Medline: 11864795]
5. Lear SA, Ignaszewski A, Linden W, Brozic A, Kiess M, Spinelli JJ, et al. The Extensive Lifestyle Management Intervention (ELMI) following cardiac rehabilitation trial. Eur Heart J 2003 Nov; 24(21):1920-1927 [FREE Full text] [Medline: 14585250]
6. Redfern J, Briffa T, Ellis E, Freedman SB. Choice of secondary prevention improves risk factors after acute coronary syndrome: 1-year follow-up of the CHOICE (Choice of Health Options In prevention of Cardiovascular Events) randomised controlled trial. Heart 2009 Mar; 95(6):468-475. [doi: 10.1136/hrt.2008.150870] [Medline: 18801781]
7. Lear SA, Spinelli JJ, Linden W, Brozic A, Kiess M, Frohlich JJ, et al. The Extensive Lifestyle Management Intervention (ELMI) after cardiac rehabilitation: A 4-year randomized controlled trial. Am Heart J 2006 Aug; 152(2):333-339. [doi: 10.1016/j.ahj.2005.12.023] [Medline: 16875919]
8. Neubeck L, Freedman SB, Briffa T, Bauman A, Redfern J. Four-year follow-up of the Choice of Health Options In prevention of Cardiovascular Events randomized controlled trial. Eur J Cardiovasc Prev Rehabil 2011 Apr; 18(2):278-286. [doi: 10.1097/HJR.0b013e32833cca66] [Medline: 20606594]
9. Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. BMC Med 2010; 8:18 [FREE Full text] [doi: 10.1186/1741-7015-8-18] [Medline: 20334633]
10. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, European Society of Cardiology (ESC), European Association for Cardiovascular PreventionRehabilitation (EACPR), Council on Cardiovascular Nursing, European Association for Study of Diabetes (EASD), International Diabetes Federation Europe (IDF-Europe), European Stroke Initiative (EUSI), International Society of Behavioural Medicine (ISBM), European Society of Hypertension (ESH), European Society of General Practice/Family Medicine (ESGP/FM/WONCA), European Heart Network (EHN). European guidelines on cardiovascular disease prevention in clinical practice: Executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007 Sep; 14 Suppl 2:E1-40. [doi: 10.1097/01.hjr.0000277984.31558.c4] [Medline: 17726406]
11. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, European Society of Hypertension. Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document. J Hypertens 2009 Nov; 27(11):2121-2158. [doi: 10.1097/HJH.0b013e328333146d] [Medline: 19838131]
12. Fitzpatrick P, Fitz-Simon N, Lonergan M, Collins C, Daly L. Heartwatch: The effect of a primary care-delivered secondary prevention programme for cardiovascular disease on medication use and risk factor profiles. Eur J Cardiovasc Prev Rehabil 2011 Feb; 18(1):129-135. [doi: 10.1097/HJR.0b013e32833cca7d] [Medline: 20606593]
13. DeBusk RF, Miller NH, Superko HR, Dennis CA, Thomas RJ, Lew HT, et al. A case-management system for coronary risk factor modification after acute myocardial infarction. Ann Intern Med 1994 May 1; 120(9):721-729. [Medline: 8147544]
14. Vale MJ, Jelinek MV, Best JD, Dart AM, Grigg LE, Hare DL, et al. Coaching patients On Achieving Cardiovascular Health (COACH): A multicenter randomized trial in patients with coronary heart disease. Arch Intern Med 2003; 163(22):2775-2783. [doi: 10.1001/archinte.163.22.2775] [Medline: 14662633]
15. Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, World Heart Federationthe Preventive Cardiovascular Nurses Association. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: A guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 2011 Nov 29; 124(22):2458-2473 [FREE Full text] [doi: 10.1161/CIR.0b013e318235eb4d] [Medline: 22052934]
16. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, European Association for Cardiovascular Prevention & Rehabilitation (EACPR), ESC Committee for Practice Guidelines (CPG). European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012 Jul; 33(13):1635-1701 [FREE Full text] [doi: 10.1093/eurheartj/ehs092] [Medline: 22555213]
17. Wister A, Loewen N, Kennedy-Symonds H, McGowan B, McCoy B, Singer J. One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk. CMAJ 2007 Oct 9; 177(8):859-865 [FREE Full text] [doi: 10.1503/cmaj.061059] [Medline: 17923653]